Placebo response in the treatment of panic disorder

Robert M.A. Hirschfeld

Research output: Contribution to journalReview articlepeer-review

17 Scopus citations


A review of key placebo-controlled studies of benzodiazepines and selective serotonin reuptake inhibitors (SSR Is) over the past decade challenges the widespread view that placebo response rates resulting from clinical trials of pharmacotherapy for panic disorder are excessively high. Statistically and clinically significant drug-placebo differences have been demonstrated in large-scale trials. Further research is needed on the impact of pharmacological treatments on the medium- and long-term course of the disorder.

Original languageEnglish (US)
Pages (from-to)A76-A86
JournalBulletin of the Menninger Clinic
Issue number2 SUPPL.
StatePublished - Mar 1996

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Placebo response in the treatment of panic disorder'. Together they form a unique fingerprint.

Cite this